Cleanroom Editorial and News
-
Cell & Gene Therapy Manufacturing: Considerations For Early-Stage Companies
1/17/2025
Key considerations for early-stage cell and gene therapy companies include whether to develop and manufacture internally vs. externally, locally vs. not, and how to choose a CDMO.
-
Your Environmental Monitoring Can't Be Your Only Line Of Defense
9/1/2025
Environmental monitoring (EM) is essential, but it’s only part of the picture. Discover why a proactive contamination control strategy is key to keeping your cleanroom truly audit-ready.
-
Solutions For Safe, Efficient, And High-Purity Automation Applications
6/12/2025
At this year’s Automatica trade fair, the Fraunhofer Institute for Manufacturing Engineering and Automation IPA will be showcasing numerous solutions that – thanks in part to artificial intelligence (AI) – greatly simplify and accelerate the planning, programming, and training of robots.
-
Use Of Conductivity As A Tool For On-Site Residue Management
3/7/2025
Residues from cleaning and disinfection are under increased scrutiny in cleanrooms. A new method using conductivity measurements offers a more accurate and objective way to quantify these residues.
-
“Futureproofing” Cleanroom Facilities
1/10/2024
Explore factors that can impact the flexibility of your biopharmaceutical facility and cleanrooms as new designs are "futureproofed" to allow for a rapid response to changes in market demands.
-
Biofluorescent Particle Counters Are Gaining Momentum
4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
A "Particular" Problem For Cell Therapy Products, Part 1: Extrinsic And Intrinsic Particles
8/19/2024
As most cell therapy products are administered intravenously, they need to comply with requirements for particulate matter. This article shares risk mitigation steps and strategies for testing and release.
-
FAQs On The Revised EU GMP Annex 1: Volume 3
9/21/2025
The EU GMP Annex 1 revision, effective August 2023, requires a detailed Contamination Control Strategy. Learn how it impacts global manufacturers, RABS use, and personnel procedures.
-
Ensuring Repeatable, Viable Surface Sampling In Aseptic Settings
2/14/2025
Without high quality data, surface sampling simply becomes another exercise in checking regulatory compliance boxes.
-
Operating And Maintaining Pharmaceutical Gas Distribution Systems
9/12/2025
Drug manufacturers face stringent requirements when using gas that comes into direct contact with the product. This guide discusses operation, maintenance, and monitoring of gas systems.